Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer. Li W, Liu Z, Jin K, Shao F, et al. BMC Cancer 2023;23:661.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li W, Liu Z, Jin K, Shao F, et al. Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer. BMC Cancer 2023;23:661.
PMID: 37452272